Company / Operating Income
Xenetic Biosciences, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$4.2M
FY2025
5-year range
-$13.9M / -$4.2M
FY2021-FY2025
Trend
+6.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$47M in FY2017 to -$4M in FY2018.
Based on SEC 10-K filings.
-$4M in FY2025.
Improved from -$7M to -$4M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 6.9% year-over-year.
- Peak operating income was recorded in FY2018.
- Lowest operating income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.2M | +6.9% |
| FY2024 | -$4.5M | +32.8% |
| FY2023 | -$6.7M | -16.9% |
| FY2022 | -$5.7M | +58.8% |
| FY2021 | -$13.9M | -8.2% |
| FY2020 | -$12.9M | -77.1% |
| FY2019 | -$7.3M | -103.9% |
| FY2018 | -$3.6M | +92.5% |
| FY2017 | -$47.4M | -382.9% |
| FY2016 | -$9.8M | -14.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026